Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment

被引：0
作者：
Antoinette MaassenVanDenBrink
Gisela M. Terwindt
Arn M. J. M. van den Maagdenberg
机构：
[1] Erasmus MC,Department of Internal Medicine, Division of Vascular Medicine and Pharmacology
[2] Leiden University Medical Centre,Department of Neurology
[3] Leiden University Medical Centre,Department of Human Genetics
来源：
Genome Medicine | / 10卷
关键词：
Calcitonin Gene-related Peptide (CGRP); Chronic Migraine; Erenumab; Fremanezumab; Receptor Activity-modifying Proteins (RAMP1);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
引用
收藏
相关论文
共 47 条
  • [21] Hallström Y(undefined)undefined undefined undefined undefined-undefined
  • [22] Broesner G(undefined)undefined undefined undefined undefined-undefined
  • [23] Bonner JH(undefined)undefined undefined undefined undefined-undefined
  • [24] Zhang F(undefined)undefined undefined undefined undefined-undefined
  • [25] Silberstein SD(undefined)undefined undefined undefined undefined-undefined
  • [26] Dodick DW(undefined)undefined undefined undefined undefined-undefined
  • [27] Bigal ME(undefined)undefined undefined undefined undefined-undefined
  • [28] Yeung PP(undefined)undefined undefined undefined undefined-undefined
  • [29] Goadsby PJ(undefined)undefined undefined undefined undefined-undefined
  • [30] Blankenbiller T(undefined)undefined undefined undefined undefined-undefined
12345